| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |